USP Zdrowie buys new production site to accommodate anticipated growth

USP Zdrowie, one of the country’s leading OTC manufacturers, on 4 October announced the acquisition of a new production facility in its native Wroclaw, to which it plans to transfer its manufacturing operations over the next few years.

The existing production site in Ziebicka street offers little room for development. Taking into account the changing and challenging business environment, constantly growing consumer needs, and the need to ensure comfortable working conditions for staff, the decision was taken to relocate production.

Founded in 1992, USP Zdrowie’s brands include e.g. Ibuprom, Apap, Gripex, Vigor UP!, Verdin, Xenna, Stoperan, or Artresan.